Intracellular transactivation of the insulin-like growth factor I receptor by an epidermal growth factor receptor
- PMID: 8601418
- DOI: 10.1006/excr.1996.0096
Intracellular transactivation of the insulin-like growth factor I receptor by an epidermal growth factor receptor
Abstract
Growth factor receptors may be transactivated not only by homologous receptors, but also by heterologous receptors. We have investigated this possibility, using for this purpose R-/EGFR cells, which are mouse embryo cells devoid of IGF-I receptors, but overexpressing the EGF receptor. At variance with mouse embryo cells with a wild-type number of IGF-I receptors and overexpressing the EGF receptor, R-/EGFR cells cannot grow in EGF only, nor can they form colonies in soft agar. However, if a wild type human IGF-I receptor is stably transfected into R-/EGFR cells, growth in EGF and colony formation in soft agar are restored. To determine a possible interaction between the two receptors, we transfected into R-/EGFR cells a number of IGF-I receptor mutants with different impaired functions. The only IGF-I receptor that cannot reverse the growth phenotype of R-/EGFR cells is a receptor with a point mutation at the ATP-binding site. All other mutant receptors, even when incapable of responding to IGF-I with a mitogenic signal, made R-/EGFR cells fully capable of responding with growth to EGF stimulation. IGF-I receptor mutants that are mitogenic but not transforming made R-/EGFR cells grow in EGF only, but were incapable of inducing the transformed phenotype. The mutant IGF-I receptors are activated (tyrosyl phosphorylation of IRS-I) in response to EGF. These experiments indicate that certain IGF-I receptor mutants with loss of function can be reactivated intracellularly by an overexpressed EGF receptor and confirm that the C-terminus of the IGF-IR is required for its transforming activity.
Similar articles
-
Dissociation of mitogenesis and transforming activity by C-terminal truncation of the insulin-like growth factor-I receptor.Exp Cell Res. 1995 May;218(1):370-80. doi: 10.1006/excr.1995.1168. Exp Cell Res. 1995. PMID: 7737373
-
Mathematical model for the effects of epidermal growth factor receptor trafficking dynamics on fibroblast proliferation responses.Biotechnol Prog. 1992 Mar-Apr;8(2):132-43. doi: 10.1021/bp00014a007. Biotechnol Prog. 1992. PMID: 1368006
-
Insulin-like growth factor receptor as a therapeutic target in head and neck cancer.Clin Cancer Res. 2007 Jul 15;13(14):4291-9. doi: 10.1158/1078-0432.CCR-06-2040. Clin Cancer Res. 2007. PMID: 17634559
-
Gene regulation by IGF-I.Mol Reprod Dev. 1993 Aug;35(4):353-6; discussion 356-7. doi: 10.1002/mrd.1080350406. Mol Reprod Dev. 1993. PMID: 8398113 Review.
-
Insulin-like growth factor-I receptor. Its role in cell proliferation, apoptosis, and tumorigenicity.Lab Invest. 1995 Sep;73(3):311-31. Lab Invest. 1995. PMID: 7564264 Review.
Cited by
-
Role of insulin-like growth factor I signaling in neurodegenerative diseases.J Mol Med (Berl). 2004 Mar;82(3):156-62. doi: 10.1007/s00109-003-0499-7. Epub 2003 Nov 28. J Mol Med (Berl). 2004. PMID: 14647921 Review.
-
Mystique is a new insulin-like growth factor-I-regulated PDZ-LIM domain protein that promotes cell attachment and migration and suppresses Anchorage-independent growth.Mol Biol Cell. 2005 Apr;16(4):1811-22. doi: 10.1091/mbc.e04-12-1052. Epub 2005 Jan 19. Mol Biol Cell. 2005. PMID: 15659642 Free PMC article.
-
Receptor heterodimerization: essential mechanism for platelet-derived growth factor-induced epidermal growth factor receptor transactivation.Mol Cell Biol. 2001 Oct;21(19):6387-94. doi: 10.1128/MCB.21.19.6387-6394.2001. Mol Cell Biol. 2001. PMID: 11533228 Free PMC article.
-
Gene expression analysis of biological systems driving an organotypic model of endometrial carcinogenesis and chemoprevention.Gene Regul Syst Bio. 2008;2:21-42. doi: 10.4137/grsb.s344. Gene Regul Syst Bio. 2008. PMID: 19784388 Free PMC article.
-
Treatment of gastrointestinal neuroendocrine tumors with inhibitors of growth factor receptors and their signaling pathways: recent advances and future perspectives.World J Gastroenterol. 2008 Apr 28;14(16):2461-73. doi: 10.3748/wjg.14.2461. World J Gastroenterol. 2008. PMID: 18442192 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous